Citations

Clear

97 citation(s) found for "Min, Paul".

Evaluation discrepancy between [ 18 F]MK‐6240 and [ 18 F]AV‐1451 tau‐PET using tau‐PET overlap index
Lim, Seokbeen , Brunn, Jessica L., Soleimani‐Meigooni, David N., Oh, Hwamee, Fortea, Juan M., Pascual, Belen, Gordon, Brian A., Rosa‐Neto, Pedro, Baker, Suzanne L. , Povala, Guilherme, Pascoal, Tharick A, Lowe, VJ, Min, Hoon-Ki Paul , Soleimani‐Meigooni, David N. , Oh, Hwamee , Fortea, Juan , Pascual, Belén , Gordon, Brian A. , Rosa-Neto, Pedro , Lussier, Firoza Zubeida , Povala, Guilherme , Pascoal, Tharick Ali

Mayo Clinic

Alzheimer's & Dementia | January 11, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106145 Get It

Abstract Background The overlap index (OI), previously introduced by Lee et al. (2022), has proven to be a reliable method for detecting tau accumulation via tau‐PET imaging with flortaucipir ([ 18 F]AV‐1451). This technique identifies voxel‐wise increases in standardized uptake value ratio (SUVr) across serial scans. However, the relationship between tau‐PET measurements obtained with [ 18 F]MK‐6240 and [ 18 F]AV‐1451 using the OI remains unclear. This study aims to investigate the relationship between [ 18 F]MK‐6240 and [ 18 F]AV‐1451 tau‐PET using the tau‐PET OI. Method The study included 27 participants from the HEAD project, all of whom underwent two serial tau‐PET scans (each [ 18 F]MK‐6240 and [ 18 F]AV‐1451) along with 3T T1‐weighted MRI, acquired within an average interval of 18 months. SUVr maps for each tau‐PET tracer were normalized to the cerebellar crus grey matter, and MR images were co‐registered to the MCALT T1 template. Tau‐PET images were spatially resampled to the template space, and OI was computed within a predefined META‐ROI using an intensity threshold of 1.3 and a cutoff of 0.5. Clusters containing fewer than 20 contiguous voxels were excluded from analysis. The META‐ROI SUVr was calculated as the average SUVr across the selected region's SUVr. Additionally, a visual comparison was performed to assess the spatial overlap of OI‐identified voxels between the two tau‐PET tracers. Result OI values within the META‐ROI exhibited a broad distribution between [ 18 F]MK‐6240 and [ 18 F]AV‐1451 tau‐PET, particularly in cognitively unimpaired (CU) and younger individuals (Figure 1A). Unlike the OI distribution, the relationship between META‐ROI SUVr values of both tracers followed an exponential trend (Figure 1B). Visual inspection revealed that OI‐detected voxels in [ 18 F]MK‐6240 tau‐PET were frequently localized to the meninges, an established site of off‐target binding, which was not observed in [ 18 F]AV‐1451 tau‐PET (Figure 2). Conclusion The association between [ 18 F]MK‐6240 and [ 18 F]AV‐1451 tau‐PET, as assessed using the OI, exhibited considerable variability in CU and younger participants. Additionally, the presence of overlapping voxels in the meninges in [ 18 F]MK‐6240 tau‐PET highlights the need to account for and potentially exclude off‐target binding effects in these populations. The influence of meningeal signal and other off‐target binding on the OI in the temporal META‐ROI needs to be further evaluated.
Impact of Age and Sex on Extra‐Brain, Off‐Target Binding in Tau PET Scans (18F‐FTP)
Ghatamaneni, Sujala, Kim, Daneil, Nycklemoe, Marin, Choi, Yurim Claire , Apgar, Christopher, Kandimalla, Mahathi , Jacobson, David N, Kung, Tiffany, Sharma, Vamika, Hol, Haakon R. , Albertson, Sabrina M., Schwarz, Christopher G, Gunter, Jeffrey L. , Petersen, Ronald, Jack, Clifford R., Lowe, VJ, Ghatamaneni, Sujala, Apgar, Christopher J., Kung, Tiffany, Lim, Seokbeen , Lundt, Emily S. , Schwarz, Christopher G. , Petersen, Ronald, Jack, Clifford R. , Min, Hoon-Ki Paul

Mayo Clinic

Alzheimer's & Dementia | January 11, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_107719 Get It

Abstract Background The tau PET imaging with 18F‐flortacipir (18F‐FTP) has focused interest in accurately tracking longitudinal tau changes in Alzheimer's disease [1]. Thus, minimizing variability is critical. Off‐target signal has the potential to complicate interpretation of tau‐PET imaging due to potential spillover or bleed‐in effects, with increased effects seen in later stages of Alzheimer's due to cerebral atrophy and proximity of off‐target areas to relevant cortical areas[2]. Previously, we demonstrated the effect of uptake period activity on 18F‐FTP signal. With increasing recent interest in demographic factors that may affect off‐target binding, we investigated the effect of age in extra‐cerebral off‐target signal in 18F‐FTP PET imaging. Method Standard 18F‐FTP PET protocol was performed in 330 participants. Two independent readers measured tau uptake in predetermined off‐target regions, including extraocular muscle, meninges, and occipital bone among others. Linear regression models assessed the relationship between participants’ age, sex, and tau uptake values (SUV and SUVr) (SUV = (Tissue radioactivity concentration / Injected dose) / Body weight & SUVr = SUV of target region/ SUV of reference region.) Result Sex had a significant effect on off‐target signal in most brain regions, with variable positive or negative correlation based on area. Notably, SUV in the eyeball‐retina, occipital bone, upper skull meninges all showed significant positive correlation with sex, with ‘male’ status generally associated with lower SUV. The greatest effect of sex was observed in superior skull meninges, occipital bone, and internal carotid artery ( p <0.001). Age showed minimally affected SUV and SUVr in off‐target regions. SUVr values show a significant correlation with SUV values of upper skull meninges in sex. Cognitive status did not significantly affect off‐target SUV. Conclusion We observed that sex significantly affected extra‐brain off‐target signal in 18F‐FTP PET imaging, while age has minimal effect, adding to previous evidence of off‐target binding within brain regions. Further evaluation is necessary to understand the age‐related effects on off‐target regions. As a result, the variability introduced by sex may pose challenges to studying tau accumulation.
The Binding Patterns of Neurofibrillary Tangles Observed With High‐Resolution Autoradiography of 18 F MK 6240 and 18 F AV1451 Are Comparable and Predomina
Ghatamaneni, Sujala, Hruska, Courtney, Shin, Ian, Lee, Jeyeon, Fang, Ping , Wood, Ashley C., Constantopoulos, Eleni , Reichard, R. Ross, Jones, David T., Schwarz, Christopher G, Radford, Jonathan Graff, Knopman, David S., Jack, Clifford R., Petersen, Ronald, Dickson, Dennis W., Murray, Melissa E., Lowe, VJ, Bruinsma, Tyler J. , Min, Hoon-Ki Paul , Moloney, Christina M. , Wood, Ashley C., Reichard, R. Ross , Jones, David T. , Schwarz, Christopher G. , Knopman, David S. , Jack, Clifford R. , Petersen, Ronald, Dickson, Dennis W. , Murray, Melissa E.

Mayo Clinic

Alzheimer's & Dementia | January 10, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106581 Get It

Abstract Background An intense search is underway for tau PET tracers with enhanced capability to visualize tau aggregates. Research indicates that [18F] AV1451 and [18F]MK 6240 exhibit comparable binding properties in terms of spatial distribution and severity of tau aggregates, as observed both in‐vivo and in‐vitro. This study focused on head‐to‐head pathological comparison of both the tracers binding specificity to tangle maturity levels (pretangles, mature tangles and ghost tangles) of tau aggregates as seen on autoradiography as compared to CP‐13 (early tangle maturity marker) and PHF‐1(middling tangle maturity marker) immunohistochemical (IHC) stains in Alzheimer's disease (AD) and non‐AD tauopathies. Method Study participants included included those with AD and non‐AD tauopathies. Analyses were performed on serial 5um formalin fixed paraffin embedded postmortem human brain sections acquired from Mayo clinic brain bank. Visual assessment of colocalization with IHC as well as quantitative analyses were used. IHC sections were incubated with antibodies CP‐13 (recognizing early tangle maturity) and PHF‐1 (recognizing middling tangle maturity). Result A total of 38 participants were examined. The participants included a spectrum from normal to AD, including mild cognitive impairment (MCI) and atypical AD. Participants with N279K (4R), P301L (4R), and R406W MAPT mutations (3R+4R) were included as well. Both the tracers showed strong binding to AD tau aggregates and no or minimal binding to non‐AD tauopathies. Generally, early tangle maturity tau accumulation participants had more tau demonstrated with CP‐13 than PHF‐1 and both the tracers [18F]MK 6240 and [18F]AV 1451 binding are well correlated with the PHF‐1 staining suggesting the preference for middling tangle level and minimal to early tangles. Conclusion The emergence and validation of these new tau PET tracers have opened new opportunities for the development of more accurate diagnostic and management tools for AD. In our study on post‐mortem sections, [ 18 F]MK‐6240 and [ 18 F]Flortaucipir showed similar binding profiles with preference to middling tangle maturity levels.
Longitudinal 123 I‐FP‐CIT SPECT Analysis Using DaTQUANT Software in Autopsy Confirmed Dementia with Lewy Bodies Patients
Miyagawa, Toji , Przybelski, Scott A. , Vernon, Cynthia, Forsberg, Leah K., Fields, Julie A. , Ramanan, Vijay K., Graff‐Radford, Jonathan, Jones, David T., Savica, Rodolfo, Reichard, R. Ross, Parisi, J. E, Dickson, Dennis W., Murray, Melissa E., Day, Gregory S, Graff‐Radford, Neill R., Kantarci, Kejal, Lowe, VJ, Boeve, Brad F, Vernon, Cynthia, Min, Hoon-Ki Paul , Forsberg, Leah K. , McCarter, Stuart J. , Ferman, Tanis J. , Ramanan, Vijay K. , Graff‐Radford, Jonathan , Jones, David T. , Savica, Rodolfo , Reichard, R. Ross , Nguyen, Aivi T. , Dickson, Dennis W. , Murray, Melissa E. , Day, Gregory S. , Graff‐Radford, Neill R. , Louis, Erik K. St. , Jain, Manoj , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | January 9, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_107564 Get It

Abstract Background Dementia with Lewy Bodies (DLB) has been overlooked or misdiagnosed as Alzheimer's disease (AD) dementia due to its frequent concomitant AD pathology with Lewy Body Disease (LBD) pathology. Although autopsy confirmation has been the gold standard for the precise diagnosis of DLB, time‐course 123 I‐FP‐CIT SPECT (DaT‐SPECT) findings in autopsy‐confirmed DLB are not well characterized. We previously reported that the DaTQUANT z‐score of the more affected side of the putamen has the best discriminatory power in detecting LBD pathology and nigrostriatal degeneration in dementia patients and demonstrated z‐score of −1 as the cutoff value. We sought to examine how DaT‐SPECT findings change over time in autopsy confirmed LBD patients in preparation for its use in LBD targeted clinical trials. Method Eight autopsy confirmed neocortical or limbic LBD patients who underwent two or more DaT‐SPECT were included. Nigrostriatal dopamine transporter (DaT) binding and age‐adjusted z‐scores were analyzed using the DaTQUANT 2.0 software (GE Healthcare). Result Six patients (75%) were male. The patients had 2.5±0.7 longitudinal DaT‐SPECT scans. Clinical diagnosis at initial scan was: DLB (75%), mild cognitive impairment (MCI) with REM sleep behavior disorder (RBD) (13%), and isolated RBD (iRBD) (13%). Clinical diagnosis at last scan was: DLB (88%) and iRBD (12%). All patients developed dementia during life. Mean age at initial scan/last scan/autopsy were 71.1±7.0/73.4±6.9/75.1±7.3 years old. Time from initial and last scan to autopsy were 4.0±1.9 and 1.8±1.9 years respectively. Seven patients (88%) had neocortical LBD and one (12%) had limbic LBD. Concomitant AD pathology was observed in four patients (two males (33%), two females (100%)). All patients had DaTQUANT putamen z‐score <‐1.0 at their initial scan including in MCI+RBD (‐1.76) and iRBD (‐1.53) patients. In the DLB patients at their initial scans, five (83%) had DaTQUANT putamen z‐score <‐2.0 and one (17%) had z‐score of ‐1.55. All patients (100%) showed DaTQUANT putamen z‐score <‐2.0 at their last scans. Conclusion DaTQUANT using cut‐off putamen z‐score of ‐1 was associated with underlying LBD pathology including at their iRBD and MCI stages. Nigrostriatal DaT binding tends to decline over time with DaTQUANT z‐score <‐2 at their last scans.
Assessing neuroinflammation in Alzheimer's disease: A TSPO‐PET study using ER176 and its correlation with amyloid and tau pathology
Kandimalla, Mahathi , Jacobson, David N, Lee, Jeyeon , Nycklemoe, Marin, Botha, Hugo, Graff‐Radford, Jonathan, Jones, David T., Vemuri, Prashanthi, Kantarci, Kejal, Knopman, David S., Jack, Clifford R., Petersen, Ronald, Lowe, Val J. , Lim, Seokbeen , Min, Hoon-Ki Paul , Botha, Hugo , Graff‐Radford, Jonathan , Jones, David T. , Vemuri, Prashanthi , Kantarci, Kejal , Knopman, David S. , Jack, Clifford R. , Petersen, Ronald

Mayo Clinic

Alzheimer's & Dementia | January 9, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106023 Get It

Abstract Background Neuroinflammation plays a crucial role in neuronal damage, synaptic dysfunction, and impaired neurogenesis, significantly contributing to Alzheimer's Disease (AD) progression. To address this, we assessed ER176's effectiveness in detecting neuroinflammation in cognitively unimpaired (CU) A–, CU A+, mild cognitive impairment (MCI), and AD participants, with a particular focus on their amyloid and tau status. This research aims to help identify suitable candidates for specialized treatment when adversely impacted by neuroinflammation. Method Participants from the Mayo Clinic Study of Aging were recruited for this study. The study included four participant groups: CU A– ( n = 25), CU A+ ( n = 25), MCI A+ ( n = 25), and AD ( n = 15). We explored the variations in neuroinflammation PET results among different groups. Result When compared to CU A–, both CU A+ and MCI A+ groups (Figure 1) showed greater regional neuroinflammation. AD exhibited more widely affected regions with neuroinflammation (temporal, occipital, and parietal lobes) than CU A‐ over the PVC spectrum (Figure 1). Minimally more neuroinflammation was seen (temporal lobes) in MCI A+ than CU A+ (Figure 1). AD had more widespread regional neuroinflammation vs CU A+ (Figure 1) than in MCI A+ vs CU+. The least difference in neuroinflammation is seen in MCI A+ vs AD (Figure 1). For A+ vs A‐, A+ showed more widespread neuroinflammation (Figure 2). T+ (tau>=1.29) vs T‐ (tau<1.29) showed more neuro inflammation with T+ (Figure 2). Comparisons varied modestly in significance level with PVC method (Figures 1 and 2). Conclusion The findings demonstrate that neuroinflammatory changes are associated with AD pathology. Even at early stages, neuroinflammation is associated with CU+. As the condition progresses, neuroinflammation extends to more brain regions and is associated with increased A+ and T+ pathology in MCI A+ and AD. These results suggest an early and persistent role of neuroinflammation in the progression AD pathology, indicating that therapy options could include early anti‐inflammatory intervention, even prior to clinical symptoms, along with treatment during clinical manifestations. PVC methods used may provide somewhat variable results.
Study Protocol for a Single-Arm Pilot Feasibility Trial Evaluating a Structured Breathing-Based Intervention to Reduce Burnout and Enhance Mental Well-Being Among Healthcare Professionals in Community-Based Practice Settings
Sharma, Pravesh , Osman, Rowa, Nycklemoe, Marin, Boos, Danielle M., Murph, Crystal M., Flock, Carolyn, Jacobson, David , Lim, Seokbeen , Nation, Jody L., Wilson, Melissa A. , Schüldt, K, Min, Paul H., Sharma, Pravesh , Nycklemoe, Marin, Flock, Carolyn R., Jacobson, David N., Schuldt, Kristina

Mayo Clinic

No container title available | January 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.07.26343607 Get It

Abstract Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion, and diminished clinical performance. Structured breathing practices have demonstrated promise in improving autonomic regulation and cerebral oxygenation, yet their feasibility and acceptability in real-world healthcare settings remain underexplored. Objectives This single-arm pilot feasibility trial aims to evaluate the feasibility, acceptability, and implementation appropriateness of a structured breathing-based intervention for healthcare professionals across community-based Mayo Clinic Health System (MCHS) sites. Secondary objectives include assessing usability and engagement with the mobile breathing platform, while exploratory analyses will examine preliminary signals of change in psychological well-being and cerebral hemodynamics. Methods and Analysis A total of 40 physicians and nurses reporting moderate or greater burnout will be enrolled across four MCHS sites. Participants will complete a four-month structured breathing program delivered primarily online, supported by a mobile application for practice tracking. Assessments will occur at baseline, 2 months, and 4 months, with optional functional near-infrared spectroscopy (fNIRS) measures of cerebral oxygenation collected at baseline and 4 months in a subset. Primary outcomes include (1) recruitment yield, retention, and adherence rates; (2) acceptability and participant satisfaction (survey and qualitative feedback); and (3) implementation appropriateness measured by the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). Secondary outcomes assess digital engagement and usability through mobile analytics and the System Usability Scale (SUS). Exploratory outcomes evaluate psychological indicators—burnout, depression, anxiety, perceived stress, sleep, fatigue, professional fulfillment, and resilience—and physiological endpoints (fNIRS). Analyses will be descriptive, summarizing feasibility metrics with 95% confidence intervals. Progression criteria (recruitment ≥75%, retention ≥80%, adherence ≥70%, AIM/IAM/FIM ≥4.0) will determine readiness for a definitive hybrid effectiveness–implementation trial. Ethics and Dissemination The study is approved by the Mayo Clinic Institutional Review Board (IRB # 25-009320). All participants will provide informed consent. Study procedures ensure confidentiality, cultural sensitivity, and participant safety. Data will be securely stored in REDCap and disseminated through peer-reviewed publications and scientific conference ClinicalTrials.gov ID The study has been prospectively registered at ClinicalTrials.gov (Identifier NCT07218458 ). Strengths and Limitations Evaluates a structured breathing-based intervention using both subjective and objective indicators of feasibility, including recruitment, retention, adherence, and implementation appropriateness. Integrates mobile application analytics with standardized implementation measures (AIM, IAM, FIM) to capture digital engagement and real-world usability. Incorporates functional near-infrared spectroscopy (fNIRS) to explore physiological mechanisms underlying burnout recovery, linking cerebral oxygenation to behavioral outcomes. Conducted across diverse community-based Mayo Clinic Health System sites, enhancing ecological validity and relevance to decentralized clinical settings. Limitations include the single-arm, region-restricted design, modest sample size, and reliance on volunteer participants, which constrain generalizability and preclude causal inference; exploratory outcomes are intended to guide future trial refinement.
Tau‐PET overlap index correlates with neuropathology findings in early‐Braak stage
Lee, Jeyeon, Mester, Carly , Ghatamaneni, Sujala, Senjem, Matthew L., Graff‐Radford, Jonathan, Schwarz, Christopher G, Gunter, Jeffrey L. , Kantarci, Kejal, Boeve, Brad F, Vemuri, Prashanthi, Jones, David T., Jack, Clifford R., Petersen, Ronald, Murray, Melissa E., Lowe, Val J. , Lim, Seokbeen , Min, Hoon-Ki Paul , Moloney, Christina M. , Senjem, Matthew L. , Nguyen, Aivi T. , Graff‐Radford, Jonathan , Schwarz, Christopher G. , Kantarci, Kejal , Vemuri, Prashanthi , Jones, David T. , Jack, Clifford R. , Petersen, Ronald, Murray, Melissa E.

Mayo Clinic

Alzheimer's & Dementia | January 8, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106743 Get It

Abstract Background The Overlap Index (OI) as previously published (Lee et al., 2022) is a reliable method for detecting tau accumulation using tau‐PET imaging (flortaucipir; AV1451). It identifies voxel‐wise standardized uptake value ratio (SUVr) elevations across serial scans. Although OI showed more sensitivity to tau signal elevation and longitudinal change than standard ROI measures, to our knowledge, the relationship of the tau PET overlap index to neuropathologic findings is still unclear. This study aims to investigate the potential of OI to detect NFTs of the neuropathologic Braak tangle stage, especially the early Braak tangle stage (I–IV). Method This study included 57 participants from the Mayo Clinic Study of Aging or Mayo Alzheimer's Disease Research Center, all of whom underwent autopsy and at least two serial AV1451 tau‐PET scans and 3T T1‐weighted MRI within an average of 16 months. Tau‐PET SUVr images were normalized to cerebellar crus grey matter, and MR images were co‐registered to a single‐subject MRI mean. Tau‐PET scans were resampled into MRI space, and OI was calculated by applying intensity thresholds 1.3. Clusters with fewer than 20 contiguous voxels were excluded. An OI cutoff of 0.5 was used and an SUVr cutoff of 1.29. Postmortem immunohistochemistry (IHC) using phospho‐tau antibodies (AT8, PHF‐1) was performed on the amygdala, temporal cortex (middle and superior), and anterior/posterior hippocampus. Neuropathological Braak staging was determined based on AT8‐stained sections. We conducted visual comparison of tau‐PET overlap signal in these regions with IHC‐confirmed tau pathology across Braak tangle stages. Result OI‐detected voxels corresponded to NFT distribution across Braak stages. In early Braak stages, standard SUVr‐based META‐ROI values remained negative, whereas OI showed positive signals, indicating greater sensitivity to early tau pathology (Figure 1). The spatial distribution of OI‐derived overlap regions aligned with high NFT burden, suggesting that OI captures early‐stage tau pathology more effectively than conventional SUVr methods. Conclusion OI in serial tau‐PET imaging demonstrated better detection of early‐stage tau pathology than standard ROI‐based SUVr measures. The alignment between OI‐detected voxels and neuropathological tau burden supports its potential as an in vivo biomarker for detecting early neurofibrillary tangles.
Breath‐Triggered Signals Observed in Resting‐State BOLD fMRI
Kang, Daehun, Min, Paul H, Lee, Jeyeon, Shu, Yunhong , Min, Paul H., Lim, Seokbeen , Lee, Jeyeon, Lapid, Maria I.

Mayo Clinic

Alzheimer's & Dementia | December 26, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_103789 Get It

Abstract Background Respiration has traditionally been considered a source of artifact in functional MRI (fMRI) due to chest motion. However, the respiratory cycle also induces changes in local oxygen concentration, resulting in fluctuations in the fMRI signal. These breathing‐triggered signals (BTS) may reflect underlying oxygen metabolism. This preliminary study developed a method to extract BTS from resting‐state BOLD fMRI and examined differences between healthy and mild cognitive impairment (MCI) groups. Method MRI scans were conducted under IRB approval on a compact 3T MRI system. Participants included two groups of 18 healthy volunteers (42.6±16.0 years) and 12 MCI patients (70.9±7.3 years). Each MRI scan included T 1 ‐weighted anatomy imaging and multi‐echo resting‐state fMRI acquisitions. The preprocessing pipeline was implemented by AFNI and FreeSurfer. Figure 1 illustrates the workflow for extracting and averaging fMRI data based on respiratory or cardiac cycle windows. As depicted in Figure 2(c,d), the mean fMRI signals corresponding to the breathing or cardiac cycles were modeled using a low‐order Fourier series to assess their amplitudes. A linear mixed‐effects model was employed to examine the effects of group and breathing cycle period, using MATLAB's ‘fitlme’ function with the formula: BTS ∼ Period + Group. Result As shown in Figure 2(e,f), breathing‐triggered BOLD signals were prominent, while cardiac‐driven BOLD signals were rarely observed. Figure 2(g) shows that global BTSs in the healthy group exhibited a linear relationship with the breathing cycle period, persisting even after artifact correction (RETROICOR for respiration and cardiac cycles and RVT). Figure 3 highlights significant regional differences between groups, particularly in the hippocampus and thalamus ( p < 0.05, uncorrected), where BTS amplitudes were greater in the MCI group. Potentially, the detected BTS could provide some insights into the coupling between respiration and cerebral oxygen metabolism and potentially serve as an imaging biomarker to assess brain health. However, due to the limited number of samples, these findings should be interpreted with caution, and further analysis is needed. Conclusion This preliminary study suggests that breathing‐triggered signals in resting‐state BOLD fMRI have the potential to serve as a noninvasive biomarker for early detection and monitoring of neurodegenerative conditions such as MCI.
Assessing the relationship of systemic proinflammatory biomarkers in the Alzheimer's disease cognitive spectrum using ER176 neuroinflammation PET
Jacobson, David N, Kandimalla, Mahathi , Lee, Jeyeon , Min, Paul H, Botha, Hugo, Graff‐Radford, Jonathan, Jones, David T., Vemuri, Prashanthi, Kantarci, Kejal, Knopman, David S., Jack, Clifford R., Petersen, R. C., Lowe, Val J. , Lim, Seokbeen , Lundt, Emily S. , Min, Paul H., Botha, Hugo , Graff‐Radford, Jonathan , Jones, David T. , Vemuri, Prashanthi , Kantarci, Kejal , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | December 24, 2025 | Volume: 21 | Issue: S1 | Pages: No page available

10.1002/alz70855_106903 Get It

Abstract Background Some data suggest that neuroinflammation may be associated with pro‐inflammatory states in the body. Systemic, proinflammatory cytokines (TNFα, IL‐1, IL‐6, etc.) are produced by a variety of comorbidities. Neuroinflammation has been shown to be associated with the accumulation of amyloid in the brain (Becher, Heneka). We hypothesized that systemic cytokine production could be associated with neuroinflammation and thereby be related to brain amyloid accumulation. This study aims to evaluate the relationship between neuroinflammation, amyloid accumulation and systemic cytokines. Method 90 participants from the Mayo Clinic Study of Aging (MCSA) received a fasting cytokine panel over a 5‐year span where IL‐1, IL‐6, IL‐10, TNFa levels were measured. Participants were divided into four groups: cognitively unimpaired with normal levels of amyloid (CU A‐, n = 25), cognitively unimpaired with elevated amyloid (CU A+, n = 25), and mild cognitively impaired (MCI) with amyloid positive (MCI A+, n = 25), and Alzheimer's disease (AD) with elevated amyloid (AD A+, n = 15). To compare regional standardized uptake value ratio (SUVr) from neuroinflammation PET based on amyloid status (A+ vs A‐) and the four cytokines, Spearman's rank correlation and Fishers r‐to‐z transformations were used to assess pairwise group differences. Result Using Spearman's rank correlation and Fishers r‐to‐z transformations, no strong relationship was found between systemic inflammation and neuroinflammation. While comparing CUA‐ vs CUA+ in Figure 1, three regions (supplementary motor area, frontal superior medial lobe, and middle cingulate cortex) showed a significant difference ( p < 0.05). However, Figure 2 showed an overarching trend bias towards significance across most regions in IL10, IL6, and TNFa. Conclusion Although significant relationships between systemic inflammation, brain amyloid and neuroinflammation were limited, the data show an overarching trend bias in broad brain regions, suggesting that further analyses are needed, possibly with larger sample sizes, to assess the relationship of regional neuroinflammation and amyloid to systemic inflammation. Future analyses could also regress out factors like sex, age, and genotype to further proinflammatory cytokine research.
Prediction of neuropathology using the FDG‐PET based patient similarity network
Zhang, Gemeng , Barnard, Leland, Botha, Hugo, Gogineni, Venkatsampath, Graff‐Radford, Jonathan, Huls, Sean J. , Stricker, John L. , Fan, Winnie Z. , Wiste, Heather J. , Machulda, Mary M., Murray, Melissa E., Reichard, R. Ross, Gunter, Jeffrey L. , Schwarz, Christopher G, Kantarci, Kejal, Whitwell, Jennifer L., Josephs, K., Knopman, David S., Boeve, Brad F, Petersen, Ronald, Jack, Clifford R., Lowe, Val J. , Jones, David T., Barnard, Leland R , Botha, Hugo , Corriveau‐Lecavalier, Nick , Graff‐Radford, Jonathan , Burkett, Brian J. , Johnson, Derek R. , Khurana, Aditya , Min, Hoon-Ki Paul , Senjem, Matthew L. , Machulda, Mary M. , Murray, Melissa E. , Dickson, Dennis W. , Nguyen, Aivi T. , Reichard, R. Ross , Schwarz, Christopher G. , Kantarci, Kejal , Whitwell, Jennifer L. , Knopman, David S. , Petersen, Ronald, Jack, Clifford R. , Jones, David T.

Mayo Clinic

Alzheimer's & Dementia | December 24, 2025 | Volume: 21 | Issue: S1 | Pages: No page available

10.1002/alz70855_103746 Get It

Abstract Background Neuropathologic evaluation is essential for diagnosing and treating dementia, but definitive diagnoses is only available after post‐mortem brain autopsy. Positron emission tomography (PET) offers a potential in vivo proxy for predicting neuropathology. This study proposes a semi‐supervised learning (SSL) model using a single FDG‐PET image to predict underlying neuropathology. Method The SSL model leverages a self‐organized graph structure based on a patient similarity network (PSN) created from 1,495 FDG‐PET images across the aging and neurodegenerative spectrum. Each patient is represented by a node, with edges indicating image similarity derived from principal component analysis features and cosine similarity weights. The PSN structure connects 20 nearest neighbors. Neuropathologic labels were available for 204 autopsied patients. The Poisson Learning Method was employed to propagate labels from these annotated nodes to unlabeled nodes, guided by the PSN structure. FDG‐PET images were collected from clinical and research participants at the Mayo Clinic and processed using an MRI‐free pipeline. Neuropathologic labels were assigned based on widely accepted diagnostic criteria. Leave‐one‐out cross‐validation (LOOCV) was used to assess model performance. Results The confusion matrix demonstrated high accuracy in predicting Alzheimer's disease, frontotemporal lobar degeneration with tau inclusions, and Lewy body disease pathology. A Sankey diagram and label distribution analysis revealed strong correlations between clinical and predicted neuropathologic labels. Conclusion This study highlights the potential of a graph‐based SSL pipeline to predict neuropathological changes using FDG‐PET imaging data, despite limited pathology labels. The findings underscore the value of SSL in bridging the gap between abundant neuroimaging data and scarce neuropathologic labels, contributing to improved dementia diagnosis and understanding.